Search for: "KING PHARMACEUTICALS, INC." Results 141 - 160 of 212
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 May 2010, 4:00 am by FDABlog HPM
District Court for the District of New Jersey (King Pharmaceuticals Inc., King Pharmaceuticals Research and Development Inc., Pharmaceutical IP Holding Inc. v. [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
II) – This case stems from a February 2009 challenge by the FTC and the California Attorney General concerning  Solvay Pharmaceuticals, Inc. [read post]
1 Apr 2010, 1:42 pm by Bexis
Novartis Pharmaceuticals Corp., 2000 WL 33915848 (E.D. [read post]
16 Mar 2010, 11:32 am by Ben Vernia
The Department of Justice announced on March 16 that Alpharma, Inc., a subsidiary of Bristol, Tennessee-based King Pharmaceuticals, Inc., has paid $42.5 million to settle allegations brought by a whistleblower that it paid health care professionals to prescribe its morphine-derived drug, Kadian. [read post]
2 Feb 2010, 11:25 am by Editor
Those who took the time and made the effort to nominate their personal recommendations for Blawg Review of the Year 2009 know how daunting a task it is to single out a half dozen outstanding presentations of Blawg Review in 2009. [read post]
2 Feb 2010, 11:25 am by Editor
Those who took the time and made the effort to nominate their personal recommendations for Blawg Review of the Year 2009 know how daunting a task it is to single out a half dozen outstanding presentations of Blawg Review in 2009. [read post]
26 Jan 2010, 7:06 am
Frank Brown ** Dean, INSEAD, France Panellists Kris Gopalakrishnan ** Chief Executive Officer and Managing Director, Infosys Technologies, India Jeffrey Joerres ** Chairman and Chief Executive Officer, Manpower Inc., USA Wallace King ** Chief Executive Officer, Leighton Holdings, Australia Fred van Leeuwen ** General Secretary, Education International, Belgium Lubna S. [read post]
28 Dec 2009, 5:29 pm
By Eric Goldman King Pharmaceuticals, Inc., v ZymoGenetics, Inc., 2009 WL 4931238 (E.D. [read post]
4 Nov 2009, 9:28 pm
On Nov. 2, King Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development, Inc., and Gentrac, Inc., filed suit against Seattle-based ZymoGenetics, Inc., in the Eastern District of Tennessee. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]